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requested the Alzheimer’s Association evaluate and report on the state of the evidence on modifiable
risk factors for cognitive decline and dementia. This report is a summary of the Association’s eval-
uation, which was presented at the October 2014 WDC meeting. The Association believes there is
sufficient evidence to support the link between several modifiable risk factors and a reduced risk
for cognitive decline, and sufficient evidence to suggest that some modifiable risk factors may be
associated with reduced risk of dementia. Specifically, the Association believes there is sufficiently
strong evidence, from a population-based perspective, to conclude that regular physical activity and
management of cardiovascular risk factors (diabetes, obesity, smoking, and hypertension) reduce the
risk of cognitive decline and may reduce the risk of dementia. The Association also believes there is
sufficiently strong evidence to conclude that a healthy diet and lifelong learning/cognitive training
may also reduce the risk of cognitive decline.
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An estimated 47million peopleworldwide are living with
dementia in 2015 [1], and this number is projected to triple
by 2050 [2]. In the absence of a disease-modifying treatment
or cure, reducing the risk of developing dementia takes on
added importance. Even when effective treatments become
available, risk reduction will likely remain a fundamental
strategy in reducing the number of individuals affected; for
many non-communicable diseases with available treatmentsthor. Tel.: 312-335-5184; Fax: 866-875-2553.
nyder@alz.org
16/j.jalz.2015.05.016
he Authors. Published by Elsevier Inc. on behalf of the Alzhe
commons.org/licenses/by-nc-nd/4.0/).(such as diabetes, cancer, and heart disease), risk reduction
efforts remain a major component of the campaigns against
these diseases.
As a science-based advocacy organization, the
Alzheimer’s Association—the largest voluntary health
organization dedicated to Alzheimer’s disease and other
dementias—is the global nonprofit leader in Alzheimer’s
disease research and the leading resource for more than
5 million individuals living with the disease in the United
States and their caregivers. In this role, we are often asked
for both expertise and guidance related to risk reduction
for Alzheimer’s disease. The Association monitors the
science and develops its positions accordingly.imer’s Association. This is an open access article under the CC BY-NC-ND
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Germany, Italy, Japan, Russia, the United Kingdom, and
the United States—created the World Dementia Council
(WDC) [3] to provide global advocacy and leadership on
key dementia challenges. The WDC is composed of individ-
uals from around the world with a wide range of expertise
and from a wide range of disciplines. One of the WDC’s pri-
ority areas is potential risk reduction, both in the absence of
treatments and after the time at which a treatment or treat-
ments become available. However, the WDC also recog-
nized that any public health effort to address the risk
factors of cognitive decline and dementia must be grounded
in the scientific evidence and informed by the scientific liter-
ature. The WDC requested the Alzheimer’s Association
evaluate and report on the state of the evidence onmodifiable
risk factors for cognitive decline and dementia to support the
WDC in any future recommendations.
The Association’s task was not to conduct an independent
review of all published literature related to risk reduction,
but to evaluate the existing reviews, briefly summarize the
findings about the existing body of published evidence, and
draw conclusions about the current state of the science. The
Alzheimer’s Association began by reviewing the detailed re-
views prepared by the UK Health Forum for the Blackfriars
Consensus [4], Alzheimer’s Australia [5,6], Alzheimer’s
Disease International [7], andDeborahBarnes, PhD, andKris-
tine Yaffe, MD [8]. Of the articles cited in these reviews, the
Association paid particular attention to meta-analyses, sys-
tematic reviews, and Cochrane reviews; in addition, the Asso-
ciation evaluated more recently published studies on specific
modifiable risk factors. The Association consulted with
more than a dozen leading researchers and experts in the de-
mentia risk reduction field—both as part of a pre-existing
effort on risk reduction and specifically for this effort—to
obtain their input on the current state of the science and the
completeness and accuracy of our summary and conclusions.
The Alzheimer’s Association—from both a scientific and
population-based perspective—weighed the evidence for
cognitive decline and all-cause dementia based on the con-
sistency of previous reviews, meta-analyses, and scientific
peer-reviewed publications; the number and strength of indi-
vidual studies (including the number of participants, dura-
tion of the study, and diversity of the participants); and the
types of those studies (prospective, longitudinal, observa-
tional, or randomized controlled trials). The summary of
the Association’s evaluation was presented at the October
2014 WDC meeting and is presented in this report. Since
the WDC meeting, the Association has reviewed additional,
more recently published abstracts and studies, which were
added to this report. These studies did not change the orig-
inal underlying conclusions reported to the WDC.2. Summary of the evidence of individual risk factors
The greatest risk factors for late-onset “sporadic”
Alzheimer’s disease and other dementias are age [9–11],family history [12–15], and genetic susceptibility genes,
such as the Apolipoprotein E ε4 allele [16,17]. However,
none of these risk factors can be modified by medical
interventions or by individual behavior. A 2010 National
Institutes of Health (NIH) State of the Science conference
found insufficient evidence, on a clinical level, to support
the association of any modifiable risk factors and
Alzheimer’s disease [18]. The evidence in many cases
(particularly with respect to dementia as opposed to cogni-
tive decline) is inconclusive due in large part to the limited
data collected to date and the limited number of clinical
studies involving specific interventions.
However, despite the limitations of the literature, looking
at analyses and studies since the 2010 NIH State of the
Science conference and viewing the data from a
population-based health perspective rather than a clinical
perspective, we believe there is sufficient evidence: (a) to
support the association between several modifiable risk fac-
tors and a reduced risk for cognitive decline; and (b) to sug-
gest that some modifiable risk factors may be associated
with reduced risk of dementia. This report discusses these
risk factors. Conclusions are summarized in Figures 1 and 2.3. Cardiovascular risk factors
3.1. Diabetes
Based on several meta-analyses, systematic reviews, and
recent studies, more than a dozen prospective, observational,
and longitudinal studies have shown lower cognitive perfor-
mance and an increase in the risk of dementia among indi-
viduals with diabetes; on balance, the association between
diabetes and dementia appears strong, but not conclusive
[19–26]. Further, a recent meta-analysis demonstrated that
individuals with mild cognitive impairment (MCI) and dia-
betes were more likely to progress to dementia than individ-
uals with MCI and no diabetes [27]. Some evidence suggests
diabetes increases dementia risk not only through vascular
pathways but also through interactions of other biological
mechanisms related to diabetes itself [28–30].3.2. Mid-life obesity
Based on several meta-analyses, systematic reviews, and
individual studies, evidence from at least a half dozen pro-
spective studies found that mid-life obesity is associated
with an increased risk of dementia. Most postulate this is a
strong link, especially with regard to cognitive decline
[20,22,31–36]. The association may change with age, as
being overweight—and, even possibly being obese—in
later life has been associated with reduced risk of
dementia [37–41]. And, a recent, large, retrospective
cohort study found a lower risk for dementia among those
who were overweight even in midlife, while those who
were underweight had an elevated risk [42].
Fig. 1. Strength of evidence on risk factors for cognitive decline.
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Meta-analyses of clinical trials and prospective, observa-
tional, longitudinal, and cross-sectional studies, including a
Cochrane review, have not indicated a consistent relationship
between high blood pressure and dementia; there is stronger
evidence for a link with cognitive decline [43–47]. A
systematic review of meta-analyses, observational studies,
and randomized controlled trials found treatments of hyper-
tensionmay reduce the risk of cognitive decline [48]; a meta-
analysis of longitudinal studies concluded the opposite [49].Fig. 2. Strength of evidence onSimilar to data on the link between obesity and cognitive
decline/dementia, studies demonstrate that later-life hyper-
tension may be protective against cognitive decline [50,51].
3.4. Hyperlipidemia (elevated cholesterol)
Systematic reviews of prospective studies have found
mixed results for the relationship between both mid-life
and late-life high cholesterol levels and dementia, including
no association between cholesterol levels and vascular de-
mentia [52,53]. While some observational studies haverisk factors for dementia.
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levels may reduce the risk of dementia [44,54,55], a
Cochrane review and systematic reviews found no or
inconsistent evidence that use of statins reduces risk [56–
58]. The effect has not been seen to date in trials and high-
quality cohort studies.4. Lifestyle risk factors
4.1. Current smoking
According to several systematic reviews and meta-
analyses, prospective and longitudinal studies have found
strong evidence that current smoking increases the risk of
cognitive decline and possibly dementia [7,26,35,59–64].
Quitting smoking may reduce the associated risk to levels
comparable to those who have not smoked [7,63–65]. One
study of a large multi-ethnic cohort found heavy smoking
in middle-age as much as doubled the risk of later-life de-
mentia [66].
4.2. Physical activity
According to systematic reviews and meta-analyses,
more than 20 prospective, longitudinal, and cross-sectional
studies, as well as randomized controlled trials, have shown
physical activity—even in some cases, mild physical activity
such as walking—is associated with a decreased risk of
cognitive impairment and/or improved cognitive function
[35,62,67–76]. Several randomized controlled trials and a
Cochrane review of such trials have found that inactive,
but otherwise healthy, seniors who begin an exercise
program experience significantly improved cognitive
function [77,78]. Studies most consistently demonstrate
the exercise must be regular and tend toward the more
vigorous side [69–72,74]; however, to date, they have
failed to pinpoint the optimal duration of the activity, the
type and intensity of the exercise, and what period during
a person’s lifespan it should occur that would maximize
potential protective effects.
4.3. Diet
Information on the effects of various aspects of diet
(including various nutrients and vitamins, foods, or food
groups) on reducing risk is limited and conflicting. Given
that many elements of diet are interrelated and interactive,
the idea of a whole dietary pattern approach has gained
some ground. However, interpretation is challenging as die-
tary pattern often varies with other lifestyle factors and with
demographic variables that may also have an impact on risk.
A few cohort studies on the Mediterranean diet (relatively
little red meat with an emphasis on whole grains, fruits
and vegetables, fish, nuts, and olive oil) or a combined
Mediterranean-DASH (Dietary Approaches to Stop Hyper-
tension) diet suggest an association between these diets
and reduced risk [79–81].4.4. Alcohol
Meta-analyses of prospective and case control studies of
older adults suggest small or moderate alcohol consumption
by older individualsmay decrease the risk of cognitive decline
and dementia [82–84]. The evidence is not strong enough,
however, to suggest those who do not drink should start
drinking, especially when weighed against the potential
negative effects of excessive alcohol consumption, such as
an increased risk of falls among older adults [85–87].4.5. Cognitive training
A Cochrane review found three dozen randomized
controlled trials of mental engagement/cognitive training in-
terventions showing improvements in immediate and delayed
recall among those in the treatment group compared with the
control group [88]. Systematic reviews of observational
studies and randomized controlled trials reached similar con-
clusions [89,90]. However, based on these analyses, it is
unclear whether the improvement is attributed specifically
to the cognitive intervention. Despite the large number of
trials, most were fairly small, and the data overall were
inconclusive. And, as with physical activity, the “recipe” for
any successful engagement remains unknown.4.6. Social engagement
There are very few systematic reviews of the evidence on
social engagement—such as doing volunteer work, joining a
club, or going to church—as a potential protective factor
against cognitive decline or dementia [91]. Some individual
studies have shown that social activities, larger social net-
works, and a history of social contact are associated with bet-
ter cognitive function and reduced risk for cognitive decline
[92–101]. However, an independent coordinated analysis of
four longitudinal studies found no effect on cognitive
functioning [102]. Looking at the totality of the evidence,
most studies in this area are small, are combined with cogni-
tive training and/or physical activities (making it difficult to
disaggregate the potential benefits solely of social engage-
ment), and/or are too dissimilar in types of social engage-
ment to draw any conclusions.5. Other risk factors
5.1. Years of formal education
Among potentially modifiable risk factors, the most
consistent evidence surrounds years of formal education
(years of schooling in a classroom-based setting taught by
professionally trained teachers). People with more years of
formal education (measured by grade level attained and/or
college attendance) or greater literacy have a lower risk for
dementia than those with fewer years of formal education
[62,103–111].
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Solid evidence exists that moderate and severe traumatic
brain injury (TBI) increases the risk of developing certain
forms of dementia [112–117]. And those who experience
repeated head injuries (such as boxers, football players,
and combat veterans) may be at an even higher risk [118–
124]. While it is not known what specific aspect of TBI
(force, repetitiveness, etc.) leads to disrupted brain
function, these multiple studies taken together strongly
link TBI to increased risk of cognitive decline and dementia.
5.3. Depression
Meta-analyses of cohort and longitudinal studies, as well
as additional cohort studies, have shown a history of depres-
sion increases the risk for dementia [125–127]. While a
recent cohort study found depressive symptoms are
independently associated with cognitive decline [128], ques-
tions remain regarding whether depression may increase an
individual’s risk or be an early marker of brain changes asso-
ciated with dementia. In addition, the effect of treatment for
depression on subsequent cognitive functioning is not well
understood.
5.4. Sleep
Several cohort and observational studies link sleep distur-
bances (for example, insomnia and sleep apnea) to increased
risk for cognitive decline [129–137]. A recent study further
suggested that treatment for breathing disorders that occur
during sleep—specifically with continuous positive airway
pressure (CPAP)—may reduce the risk of cognitive decline
[134]. However, how the exact nature or duration of an indi-
vidual’s sleep problems are related to increased risk is not
well understood, nor is it clear whether the sleep distur-
bances are a cause of or a related precursor to dementia.6. A multivariate approach to risk reduction
Recent data from several retrospective studies have found
declining dementia prevalence or incidence rates in specific
population cohorts since the 1970s [138–142]. Some of these
studies have noted the large improvements in educational
attainment (including higher rates of graduation from high
school and college attendance) among the more recent
cohorts [138,139,142], underscoring the existing evidence
that formal education is beneficial for reducing an
individual’s risk for cognitive decline and dementia
[62,103–111]. Some studies have also noted that over the
same period of declining dementia prevalence or
incidence, cohorts of study participants had substantial
improvements in management of cardiovascular risk
factors as well as considerable declines in smoking, heart
disease, and stroke [138–140,142]. This has led to the
suggestion that medical and public health interventions to
lower various cardiovascular risk factors may have had theadditional benefit of improving cognitive health in those
specific populations [143,144]. Furthermore, some studies
have shown those with multiple vascular issues are at
higher risk for cognitive decline and each additional
vascular risk factor may be additive to the individual’s risk
of cognitive decline [145,146].
Given that most of these cardiovascular risk factors are
interrelated and connected to the general notion of a healthy
lifestyle, focusing on one single lifestyle or health factor
may be insufficient to reduce an individual’s risk of devel-
oping cognitive decline and/or dementia. Some have sug-
gested the most effective strategy may be to address
multiple risk factors simultaneously [145,147,148]. The
idea of a multivariate approach to reducing risk for
cognitive decline was tested in the Finnish Geriatric
Intervention Study to Prevent Cognitive Impairment and
Disability (FINGER)—the first published randomized
controlled trial on multivariate risk factors and cognitive
decline. Recent results from the study, which selected
subjects with higher cardiovascular risk profiles, found
overall cognitive performance as well as executive
function improved significantly with a multi-component
lifestyle intervention involving physical activity, nutritional
guidance, cognitive training, social activities, and manage-
ment of cardiovascular risk factors [149].7. Conclusions
As a result of the Association’s review of the current state
of evidence on risk factors related to both cognitive decline
and dementia, it is clear that there are still many unanswered
questions and significant uncertainty with respect to the
relationship between individual risk factors and dementia
(for example, to what degree there is a causal relationship).
There is a clear need for more research on risk reduction,
prevention, and brain health—both more longitudinal,
population-based cohort studies and randomized controlled
trials on the effectiveness of specific interventions that
address modifiable risk factors.
However, the Association also believes there is suffi-
ciently strong evidence, from a population-based perspec-
tive, to conclude: (1) regular physical activity and
management of cardiovascular risk factors (diabetes,
obesity, smoking, and hypertension) have been shown to
reduce the risk of cognitive decline and may reduce the
risk of dementia; and (2) a healthy diet and lifelong
learning/cognitive training may also reduce the risk of
cognitive decline. The Institute of Medicine, drawing on a
panel of distinguished researchers in the field, recently
examined the evidence with regard to cognitive aging and
cognitive decline and reached a virtually identical conclu-
sion [150].
The evidence has now reached a point that it can no
longer remain simply an exercise in academic discussion.
The public should know what the science concludes: certain
healthy behaviors known to be effective for diabetes,
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health and for reducing the risk of cognitive decline. For
our part, the Alzheimer’s Association is launching a new
brain health education program, Healthy Habits for a
Healthier You. It is designed to provide consumers with
the latest research and practical information on ways they
can take care of their bodies and brains to age as well as
possible.
For maximum impact, a broader effort must be under-
taken—and governments must be involved—to increase
public awareness and education about known and potentially
modifiable risk factors of cognitive decline and dementia.
Since the Association presented its conclusions, the WDC
issued a statement encouraging all nations not only to invest
in further research, but also to incorporate dementia risk
reduction and management into public health policies, pub-
lic health campaigns, and non-communicable disease strate-
gies and action plans [151]. It is a two-pronged approach:
promote risk reduction today based on the scientific evi-
dence available and pursue more research so the evidence
will be stronger and more definitive tomorrow.References
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